Mesa Laboratories (MLAB) Equity Average (2011 - 2025)

Mesa Laboratories has disclosed Equity Average across 15 years of filings, most recently posting $182.6 million for Q4 2025.

• Equity Average for Q4 2025 came in at $182.6 million, up 15.31% year-over-year; the trailing twelve-month figure through Dec 2025 was $182.6 million (up 15.31% YoY), and the FY2025 annual result was $152.6 million, down 43.36% from the prior year.
• Equity Average came in at $182.6 million for Q4 2025 at Mesa Laboratories, up from $175.5 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $409.5 million in Q1 2021 to a low of $148.1 million in Q2 2024.
• The 5-year median for Equity Average is $383.9 million (2022), against an average of $306.6 million.
• Across the five-year window, Equity Average jumped 79.9% in 2021 and tumbled 62.09% in 2024, its largest moves.
• Mesa Laboratories' Equity Average stood at $397.9 million in 2021, then slipped by 4.31% to $380.7 million in 2022, then gained by 3.85% to $395.4 million in 2023, then tumbled by 59.95% to $158.3 million in 2024, then rose by 15.31% to $182.6 million in 2025.
• The last three Equity Average figures came in at $182.6 million (Q4 2025), $175.5 million (Q3 2025), and $166.2 million (Q2 2025), per Business Quant data.